Key Points Pfizer and Novo Nordisk have underperformed the market over the past year.But both should remain major players in ...

Australian shares have rebounded impressively since April, but the real test will be the upcoming earnings season.

If you're looking for stocks that can make dramatic movements in a short time frame, the biotechnology space has what you ...

Every so often, activist investors swarm around underperforming companies in a certain industry and pressure them to change ...

One of these stocks finished the first half unchanged, and the other fell in the double-digits. Both represent great ...

Investing in biotechnology stocks is similar to the drug development process itself. That is, investors frequently experience long periods of nothing much happening, interrupted by periods of sharp ...

Unless a significant macroeconomic shock occurs, Bitcoin's mid-term prospects remain constructive, with the potential to ...